Home›People›Joseph Chiarelli
JC

Joseph Chiarelli

Executive officer and director at ATED Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Apr 2, 2026·Suggest an edit

About Joseph Chiarelli

Joseph Chiarelli is an executive officer and director at ATED Therapeutics.

Experience

This experience comes from Joseph Chiarelli's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joseph Chiarelli in the role, so the role may have started earlier or lasted longer.

M.M. Dillon & Co. Current
Managing Director
2017 – Present
ATED Therapeutics Ltd.
Executive officer and director
2026 · Greenwich, CT
Develops an investigational blood test for people with Parkinson’s disease.
Chiarelli and Company, LLC
Managing Partner
2009 – 2017
Sanuwave, Inc.
CEO
2013 – 2014
Auriga USA, LLC
Senior Managing Director
2011 – 2013
Chiarelli Healthcare Select Fund
Managing Partner
2011
Clarent Hospital Corporation
Chairman
2001 – 2009
Oppenheimer & Co
Senior Equity Analyst
2003 – 2005
JPMorgan Chase & Co.
Senior High Yield Investment Analyst, Vice President - Funds Manager, CFO and Controller
1995 – 2001

Key Colleagues at Startups

The people Joseph Chiarelli works with at each company, as listed on that company's latest Form D.

ATED Therapeutics Ltd. · Form D, Apr 2, 2026
Jeff Swarz
Jeff Swarz
Chief Executive Officer and director

Sources

  1. SECATED Therapeutics Ltd. Form D, filed Apr 2, 2026